This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Stocks in play: Sernova Biotherapeutics
Announced the closing of its non-brokered private placement financing that has secured total gross proceeds of $2.1 million. The Company issued 13,762,659 units in connection with the private placement at a price of $0.15 per unit. Sernova Biotherapeutics shares T.SVA are trading up $0.01 at $0.17.
